Literature DB >> 9626514

Metastatic squamous-cell carcinoma in pericardial effusion: report of four cases, two with cardiac tamponade.

R S Hoda1, J Cangiarella, L G Koss.   

Abstract

For reasons unknown, metastatic squamous-cell carcinoma is a rare cause of pleural effusions and is even less common in pericardial effusions. A review of all pericardial effusions examined in the Cytology Service at Montefiore Medical Center over a 15-year (1980-1994) period was undertaken (N = 251). Four cases with metastatic squamous-cell carcinoma were identified among 39 malignant effusions. Two patients with metastatic squamous-cell carcinoma presented with cardiac tamponade, and the other two cases had progressive cardiac failure. The diagnostic cells on cytology evaluation were scant in all four cases but exhibited classical features of metastatic squamous carcinoma, such as cytoplasmic keratinization, intercellular bridges, and occasional "pearl" formation. Pericardial biopsies available in three patients, two with cardiac failure and one with cardiac tamponade, were negative. In all four cases the primary tumor was a bronchogenic carcinoma. Metastatic squamous-cell carcinoma is an uncommon cause of pericardial effusion and usually indicates the presence of a bronchogenic carcinoma with a rapidly fatal outcome. Cytologic examination of pericardial fluid is essential in the evaluation of such patients.

Entities:  

Mesh:

Year:  1998        PMID: 9626514     DOI: 10.1002/(sici)1097-0339(199806)18:6<422::aid-dc7>3.0.co;2-a

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  2 in total

Review 1.  Serous cavity metastasis: Evaluation of unknown primary.

Authors:  Nirag Jhala; Aileen Arriola; Liron Pantanowitz
Journal:  Cytojournal       Date:  2022-03-19       Impact factor: 2.345

2.  Relapse with isolated peritoneal metastasis in lung adenocarcinoma: case report and review of the literature.

Authors:  Ozgur Tanriverdi; Sabri Barutca; Nezih Meydan
Journal:  Contemp Oncol (Pozn)       Date:  2013-01-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.